Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export corporate actions as CSV.

Twilight Litaka Pharma Limited

BSE: 506985
₹2.88
▼ -0.15 (-4.95%)
Jan. 1, 2015 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
9/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-44.3
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.0%
Low 2.8800 · High 2.8800
1W return
-22.0%
Low 2.8800 · High 3.5100
1M return
-18.2%
Low 2.8800 · High 4.7700
52W return
-31.6%
Low 2.8800 · High 7.0900
Lifetime High ₹196.3500 (Oct. 4, 2010)
Lifetime Low ₹1.9700 (Aug. 23, 2013)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
3.2
10D
3.5
20D
3.7
50D
4.1
100D
4.3
200D
4.7

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

2.88
Pivot
First resistance2.88
Second resistance2.88
Third resistance2.88
First support2.88
Second support2.88
Third support2.88
Day RSI27.6
Day MFI11.2
Day MACD-0.29
Day MACD signal-0.16

Beta

1M0.05
3M0.50
1Y0.59
3Y0.77

Price change analysis

↓ -18.2%
Over 1 Month
LowHigh
2.884.77
↓ -35.7%
Over 3 Months
LowHigh
2.885.16
↓ -58.7%
Over 6 Months
LowHigh
2.887.00
↓ -31.6%
Over 1 Year
LowHigh
2.887.09
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Data unavailable.

Full shareholding pattern →

DateClientDealActionQuantityPriceExchange
28 Mar 2013 Fervent Pharma Synergies Limited Bulk Sell 183,030 5.6000 BSE
4 Feb 2013 KAMAL CHANDMAL JAIN Bulk Sell 125,000 9.4800 BSE
3 May 2011 IFCI FACTORS LTD Bulk Sell 137,521 54.9600 BSE
25 Mar 2011 IFCI FACTORS LTD Bulk Sell 171,500 52.4300 BSE
24 Mar 2011 IFCI FACTORS LTD Bulk Sell 250,000 50.4400 BSE
23 Mar 2011 IFCI FACTORS LTD Bulk Sell 125,000 45.3100 BSE
16 Mar 2011 PAM PAC MACHINES PRIVATE LIMITED Bulk Sell 250,000 47.8900 BSE
15 Mar 2011 PAM PAC MACHINES PRIVATE LIMITED Bulk Sell 190,000 54.0400 BSE
14 Dec 2010 PRIMORE SOLUTIONS PVT.LTD Bulk Sell 128,782 84.7600 BSE
14 Dec 2010 PRIMORE SOLUTIONS PVT.LTD Bulk Buy 166,446 85.3500 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
22 Sep 2011 Annual General Meeting And Dividend - Rs.1.50 Per Share 1.5000 —
20 Sep 2010 Annual General Meeting And Dividend Rs.1.50 Per Share 1.5000 —

Corporate Actions

Full history (6 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Li Taka Pharamaceuticals Ltd. to Twilight Litaka Pharma Limited
24 Nov 2014OTHERAnnual General Meeting
24 Dec 2013OTHERAnnual General Meeting
21 Dec 2012OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 32 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
18 Jun 2018 Delisting Members of the Exchange are hereby notified that in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract (Regulations) Rules, 1957 and Bye Laws & Regulations of National Stock Exchange of India Limited, it has been decided to delist (withdraw the admission to dealings in) equity shares of the Twilight Litaka Pharma Limited w.e.f. July 02, 2018.
2 Feb 2018 Public Notice - Compulsory Delisting Members of the Exchange are hereby informed that the Exchange on February 02, 2018 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).
4 Aug 2016 Disclosure under Insider Trading Regulation ACG Pampac Machines Pvt Ltd has submitted to the Exchange vide letter dated July 28, 2016 a copy of disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.
4 Aug 2016 Disclosure under Insider Trading Regulation ACG Pam Pac Machines Pvt Ltd has submitted to the Exchange vide letter dated July 28, 2016 a copy of disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.
24 Dec 2014 Suspension of Trading Members of the Exchange are hereby informed that trading in the equity shares of Twilight Litaka Pharma Limited will be suspended w.e.f. January 02, 2015 (i.e. closing hours of trading on January 01, 2015) pursuant to order dated April 30, 2014 passed by the Hon'ble High Court, Bombay, in Company Petition No.471 of 2012, the Official Liquidator attached to the said Court has been appointed as the Provisional Liquidator of M/s Twilight Litaka Pharma Limited (In Liqn.).
2 Dec 2014 Annual General Meeting Updates Twilight Litaka Pharma Limited has submitted to the Exchange a copy of outcome of the Annual General Meeting of the Company held on November 29, 2014.
21 Nov 2014 AGM/Book Closure Twilight Litaka Pharma Limited has informed the Exchange that the Company has fixed Book Closure from November 26, 2014 to November 29, 2014 for the purpose of Annual General Meeting (AGM) scheduled to be held on November 29, 2014.
18 Nov 2014 Financial Result Updates Twilight Litaka Pharma Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2014.
9 Sep 2014 Financial Result Updates Twilight Litaka Pharma Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Jun-2014.
22 May 2014 Financial Result Updates Twilight Litaka Pharma Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2014.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (27.6) -- a technical rebound zone

Threats

  • Down 31.6% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Twilight Litaka Pharma Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.